Tamsulosin Hydrochloride
Product Images NDC 52959-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 52959-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Tablets Container Label (Tamsulosin HCl Capsules Container Label 100 Tablets)

100 Tablets Container Label (Tamsulosin HCl Capsules Container Label 100 Tablets)
This is a description of a medication called Tamsulosin HCL in capsule form. The lot number mentioned is TSUOOWU and the expiry date is 07/12. The medication is manufactured by Wockhardt, based in India and has an NDC code of 64679-516-02. The capsules are orange with a green e cap. The medication should be taken as directed by a doctor or following information in the outsert, which provides usual dosage information. The medication is compared to Flomax. The rest of the text appears to include instructions and warnings likely on the packaging but is not readable.*
FDA Label Image

Figure1 (Tamsulosin HCl Capsules Figure 1)

FDA Label Image

Figure 2a (Tamsulosin HCl Capsules Figure 2a)

Figure 2a (Tamsulosin HCl Capsules Figure 2a)
This appears to be a table representing a clinical trial. It includes information on treatment options, dosage, and duration, with different groups of participants represented by n values. There is also a column labeled "Mean Change" but without further information, it is unclear what this refers to.*
FDA Label Image

Figure 2b (Tamsulosin HCl Capsules Figure 2b)

Figure 2b (Tamsulosin HCl Capsules Figure 2b)
This appears to be a table showing the "Mean Change" in a treatment group compared to a placebo group over various durations of treatment, measured in weeks. There are different dosages of the treatment being compared. The exact treatment is not provided, and some characters in the table are not readable.*
FDA Label Image

Figure3a (Tamsulosin HCl Capsules Figure 3a)

FDA Label Image

Figure3b (Tamsulosin HCl Capsules Figure 3b)

FDA Label Image

Structure (Tamsulosin HCl Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.